Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01454830 · ClinicalTrials.gov registry record · Phase 1
Tailored Intervention to Promote Positive Airway Pressure Adherence
A Phase 1 study of Sleep Apnea, Obstructive and Patient Compliance, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 118
- Enrollment target
- 1
- Study location
NCT01454830 is a Phase 1 study of Sleep Apnea, Obstructive and Patient Compliance that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 118 participants, below the 260-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01454830, a Phase 1 study of Sleep Apnea, Obstructive and Patient Compliance, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 118 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the feasibility of a tailored (i.e., individualized) intervention to promote adherence to continuous positive airway pressure therapy (CPAP) in adults with newly-diagnosed, CPAP treated, obstructive sleep apnea.
Conditions Studied
Interventions
- OTHER Usual care
- BEHAVIORAL Tailored
Study Locations (1)
Pennsylvania
- Penn State Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01454830
The ClinicalTrials.gov registry entry for NCT01454830 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 45 other Sleep Apnea, Obstructive trials with a reported enrollment target (55% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Sleep Apnea, Obstructive appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT01454830 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01454830 about?
NCT01454830 is a clinical study titled "Tailored Intervention to Promote Positive Airway Pressure Adherence". The purpose of this study is to examine the feasibility of a tailored (i.e., individualized) intervention to promote adherence to continuous positive airway pressure therapy (CPAP) in adults with newly-diagnosed, CPAP treated, obstructive sleep apnea.
What is the current status of trial NCT01454830?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 118 participants. The study started on 2011-11. Estimated completion is 2014-03.
What conditions does trial NCT01454830 study?
This clinical trial studies the following conditions: Sleep Apnea, Obstructive, Patient Compliance.
What interventions are being tested in trial NCT01454830?
The interventions under investigation include: Usual care (OTHER), Tailored (BEHAVIORAL).
Who is sponsoring clinical trial NCT01454830?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01454830 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Apnea, Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine
RECRUITING · Phase 1
-
Sleep Apnea Treatment With Expiratory Resistance(Provent™)
COMPLETED · Phase 1
-
Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep
RECRUITING
-
Do Endotypes Predict Response and Sequelae in OSA Patients
RECRUITING · Phase 2
-
The PREDICTOR Study: Assessing Diagnostic Predictors of Airway Collapse in Patients With Obstructive Sleep Apnea
RECRUITING · NA
-
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.